HuGE Literature Finder
Records
1
-
28
Essential thrombocythaemia progression to the fibrotic phase is associated with a decrease in JAK2 and PDL1 levels. Annals of hematology 2022 Oct . Lewandowski Krzysztof, Kandu?a Zuzanna, Gniot Micha?, Paczkowska Edyta, Nawrocka Paulina Maria, Wojtaszewska Marzena, Janowski Micha?, Mariak Magdalena, Handschuh Luiza, Kozlowski Pio |
JAK2V617F variant allele frequency, non-driver mutations, single-nucleotide variants and polycythemia vera outcome. Journal of cancer research and clinical oncology 2022 Oct . Kandu?a Zuzanna, Janowski Micha?, Wi?ckowska Barbara, Paczkowska Edyta, Lewandowski Krzyszt |
Cardiovascular Disease Among Patients With AML and CHIP-Related Mutations. JACC. CardioOncology 2022 Mar 4 (1): 38-49. Calvillo-Argüelles Oscar, Schoffel Alice, Capo-Chichi José-Mario, Abdel-Qadir Husam, Schuh Andre, Carrillo-Estrada Montserrat, Liu Shiying, Gupta Vikas, Schimmer Aaron D, Yee Karen, Shlush Liran I, Natarajan Pradeep, Thavendiranathan Paaladine |
Association of clonal hematopoiesis mutations with clinical outcomes: A systematic review and meta-analysis. American journal of hematology 2022 1 97 (4): 411-420. Nowakowska Malgorzata K, Kim Taebeom, Thompson Mikayla T, Bolton Kelly L, Deswal Anita, Lin Steven H, Scheet Paul, Wehner Mackenzie R, Nead Kevin |
Clinical characteristics of Japanese patients with polycythemia vera: results of the JSH-MPN-R18 study. International journal of hematology 2022 7 116 (5): 696-711. Edahiro Yoko, Ito Tomoki, Gotoh Akihiko, Nakamae Mika, Kimura Fumihiko, Koike Michiaki, Kirito Keita, Wada Hideho, Usuki Kensuke, Tanaka Takayuki, Mori Takehiko, Wakita Satoshi, Saito Toshiki I, Kada Akiko, Saito Akiko M, Shimoda Kazuya, Sugimoto Yuka, Kurokawa Toshiro, Tomita Akihiro, Hashimoto Yoshinori, Akashi Koichi, Matsumura Itaru, Takenaka Katsuto, Komatsu Nor |
Rivaroxaban for the treatment of noncirrhotic splanchnic vein thrombosis: an interventional prospective cohort study. Blood advances 2022 4 6 (12): 3569-3578. Ageno Walter, Beyer Westendorf Jan, Contino Laura, Bucherini Eugenio, Sartori Maria Teresa, Senzolo Marco, Grandone Elvira, Santoro Rita, Carrier Marc, Delluc Aurélien, De Stefano Valerio, Pomero Fulvio, Donadini Marco Paolo, Tosetto Alberto, Becattini Cecilia, Martinelli Ida, Nardo Barbara, Bertoletti Laurent, Di Nisio Marcello, Lazo-Langner Alejandro, Schenone Alessandro, Riva Nicolet |
Identification of JAK2 and FOXM1 expression as novel candidate biomarkers for predicting the benefit of immunotherapy in lung squamous cell carcinoma. Annals of translational medicine 2021 Jul 9 (13): 1081. Zhang Shixin, Liu Shuai, Liu Xi, Liu Jie, Wu W |
Molecular profiling and risk classification of patients with myeloproliferative neoplasms and splanchnic vein thromboses. Blood advances 2020 8 4 (15): 3708-3715. Debureaux Pierre-Edouard, Cassinat Bruno, Soret-Dulphy Juliette, Mora Barbara, Verger Emmanuelle, Maslah Nabih, Plessier Aurelie, Rautou Pierre-Emmanuel, Ollivier-Hourman Isabelle, De Ledinghen Victor, Goria Odile, Bureau Christophe, Siracusa Claudia, Valla Dominique, Giraudier Stephane, Passamonti Francesco, Kiladjian Jean-Jacqu |
No Differences in Outcomes Between JAK2 V617F-Positive Patients with Variant Allele Fraction < 2% Versus 2-10%: A 6-Year Province-wide Retrospective Analysis. Clinical lymphoma, myeloma & leukemia 2020 5 20 (9): e569-e578. Limvorapitak Wasithep, Parker Jeremy, Hughesman Curtis, McNeil Kelly, Foltz Lynda, Karsan A |
Classical Philadelphia-negative myeloproliferative neoplasms: focus on mutations and JAK2 inhibitors. Medical oncology (Northwood, London, England) 2018 Aug 35 (9): 119. Helbig Grzego |
Impact of genotype on leukaemic transformation in polycythaemia vera and essential thrombocythaemia. British journal of haematology 2017 09 178 (5): 764-771. Alvarez-Larrán Alberto, Senín Alicia, Fernández-Rodríguez Concepción, Pereira Arturo, Arellano-Rodrigo Eduardo, Gómez Montse, Ferrer-Marin Francisca, Martínez-López Joaquín, Camacho Laura, Colomer Dolors, Angona Anna, Navarro Blanca, Cervantes Francisco, Besses Carlos, Bellosillo Beatriz, Hernández-Boluda Juan Carl |
Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation. The New England journal of medicine 2017 02 376 (6): 536-547. Lindsley R Coleman, Saber Wael, Mar Brenton G, Redd Robert, Wang Tao, Haagenson Michael D, Grauman Peter V, Hu Zhen-Huan, Spellman Stephen R, Lee Stephanie J, Verneris Michael R, Hsu Katharine, Fleischhauer Katharina, Cutler Corey, Antin Joseph H, Neuberg Donna, Ebert Benjamin |
Germline genetic variation in JAK2 as a prognostic marker in castration-resistant prostate cancer. BJU international 2016 Jul . Zhang Ben Y, Riska Shaun M, Mahoney Douglas W, Costello Brian A, Kohli Rhea, Quevedo J F, Cerhan James R, Kohli Mani |
The expression of Death Inducer-Obliterator (DIDO) variants in Myeloproliferative Neoplasms. Blood cells, molecules & diseases 2016 Jul 59 25-30. Berzoti-Coelho Maria Gabriela, Ferreira Aline Fernanda, de Souza Nunes Natalia, Pinto Mariana Tomazini, Júnior Maurício Cristiano Rocha, Simões Belinda Pinto, Martínez-A Carlos, Souto Elizabeth Xisto, Panepucci Rodrigo Alexandre, Covas Dimas Tadeu, Kashima Simone, Castro Fabíola Att |
Disease characteristics and outcomes in younger adults with primary and secondary myelofibrosis. British journal of haematology 2016 Jun . Beauverd Yan, Alimam Samah, McLornan Donal P, Radia Deepti H, Harrison Claire |
Mutations and long-term outcome of 217 young patients with essential thrombocythemia or early primary myelofibrosis. Leukemia 2015 Jun 29 (6): 1344-9. Palandri F, Latagliata R, Polverelli N, Tieghi A, Crugnola M, Martino B, Perricone M, Breccia M, Ottaviani E, Testoni N, Merli F, Aversa F, Alimena G, Cavo M, Martinelli G, Catani L, Baccarani M, Vianelli |
Impact of JAK2V617F Mutational Status on Phenotypic Features in Essential Thrombocythemia and Primary Myelofibrosis. Turkish journal of haematology : official journal of Turkish Society of Haematology 2015 Apr . Yönal Ipek, Da?lar Aday Aynur, Akadam Teker Ba?ak, Ceylan Y?lmaz, Nalcac? Meliha, Yavuz Akif Selim, Sarg?n Fatma Den |
Calreticulin mutations and long-term survival in essential thrombocythemia. Leukemia 2014 Dec 28 (12): 2300-3. Tefferi A, Wassie E A, Lasho T L, Finke C, Belachew A A, Ketterling R P, Hanson C A, Pardanani A, Gangat N, Wolanskyj A |
Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis. Blood 2014 Oct 124 (16): 2507-13; quiz 2615. Tefferi Ayalew, Guglielmelli Paola, Larson Dirk R, Finke Christy, Wassie Emnet A, Pieri Lisa, Gangat Naseema, Fjerza Rajmonda, Belachew Alem A, Lasho Terra L, Ketterling Rhett P, Hanson Curtis A, Rambaldi Alessandro, Finazzi Guido, Thiele Juergen, Barbui Tiziano, Pardanani Animesh, Vannucchi Alessandro |
Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study. Blood 2014 Apr 123 (14): 2157-60. Guglielmelli Paola, Biamonte Flavia, Rotunno Giada, Artusi Valentina, Artuso Lucia, Bernardis Isabella, Tenedini Elena, Pieri Lisa, Paoli Chiara, Mannarelli Carmela, Fjerza Rajmonda, Rumi Elisa, Stalbovskaya Viktoriya, Squires Matthew, Cazzola Mario, Manfredini Rossella, Harrison Claire, Tagliafico Enrico, Vannucchi Alessandro M, , |
Association between thromboembolic events and the JAK2 V617F mutation in myeloproliferative neoplasms. The Kurume medical journal 2014 60 (3-4): 89-97. Takata Yuka, Seki Ritsuko, Kanajii Taisuke, Nohara Masayuki, Koteda Satoko, Kawaguchi Kuniki, Nomura Kei, Nakamura Takayuki, Morishige Satoshi, Oku Eijirou, Osaki Koichi, Hashiguchi Emichitoshi, Mouri Fumihiko, Yoshimoto Koji, Nagafuji Koji, Okamura Takas |
Mutations and prognosis in primary myelofibrosis. Leukemia 2013 Sep 27 (9): 1861-9. Vannucchi A M, Lasho T L, Guglielmelli P, Biamonte F, Pardanani A, Pereira A, Finke C, Score J, Gangat N, Mannarelli C, Ketterling R P, Rotunno G, Knudson R A, Susini M C, Laborde R R, Spolverini A, Pancrazzi A, Pieri L, Manfredini R, Tagliafico E, Zini R, Jones A, Zoi K, Reiter A, Duncombe A, Pietra D, Rumi E, Cervantes F, Barosi G, Cazzola M, Cross N C P, Tefferi |
JAK2 V617F genotype is a strong determinant of blast transformation in primary myelofibrosis. PloS one 2013 8 (3): e59791. Barosi Giovanni, Poletto Valentina, Massa Margherita, Campanelli Rita, Villani Laura, Bonetti Elisa, Viarengo Gianluca, Catarsi Paolo, Klersy Catherine, Rosti Vittor |
Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations. Blood 2011 Mar 117 (10): 2813-6. Passamonti Francesco, Elena Chiara, Schnittger Susanne, Skoda Radek C, Green Anthony R, Girodon François, Kiladjian Jean-Jacques, McMullin Mary Frances, Ruggeri Marco, Besses Carles, Vannucchi Alessandro M, Lippert Eric, Gisslinger Heinz, Rumi Elisa, Lehmann Thomas, Ortmann Christina A, Pietra Daniela, Pascutto Cristiana, Haferlach Torsten, Cazzola Mar |
The JAK2 V617F somatic mutation, mortality and cancer risk in the general population. Haematologica 2010 Dec . Nielsen C, Birgens HS, Nordestgaard BG, Kjaer L, Bojesen SE |
The associations of Janus kinase-2 (JAK2) A830G polymorphism and the treatment outcomes in patients with acute myeloid leukemia. Leukemia & lymphoma 2010 Jun 51 (6): 1115-20. Zhong Yuejiao, Chen Baoan, Feng Jifeng, Cheng Lu, Li Yufeng, Qian Jun, Ding Jiahua, Gao Feng, Xia Guohua, Chen Ningna, Lu Zuho |
Identification of patients with poorer survival in primary myelofibrosis based on the burden of JAK2V617F mutated allele. Blood 2009 Aug 114 (8): 1477-83. Guglielmelli Paola, Barosi Giovanni, Specchia Giorgina, Rambaldi Alessandro, Lo Coco Francesco, Antonioli Elisabetta, Pieri Lisa, Pancrazzi Alessandro, Ponziani Vanessa, Delaini Federica, Longo Giovanni, Ammatuna Emanuele, Liso Vincenzo, Bosi Alberto, Barbui Tiziano, Vannucchi Alessandro |
JAK2V617F mutation status identifies subtypes of refractory anemia with ringed sideroblasts associated with marked thrombocytosis. Haematologica 2008 Jan 93 (1): 34-40. Schmitt-Graeff Annette H, Teo Soon-Siong, Olschewski Manfred, Schaub Franz, Haxelmans Sabine, Kirn Andreas, Reinecke Petra, Germing Ulrich, Skoda Radek |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: